BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 31926244)

  • 1. Bioinformatic identification of renal cell carcinoma microenvironment-associated biomarkers with therapeutic and prognostic value.
    Zeng Q; Zhang W; Li X; Lai J; Li Z
    Life Sci; 2020 Feb; 243():117273. PubMed ID: 31926244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database.
    Wan B; Liu B; Huang Y; Lv C
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1159. PubMed ID: 32012488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data Mining of Prognostic Microenvironment-Related Genes in Clear Cell Renal Cell Carcinoma: A Study with TCGA Database.
    Chen B; Chen W; Jin J; Wang X; Cao Y; He Y
    Dis Markers; 2019; 2019():8901649. PubMed ID: 31781309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis.
    Luo L; Zhou H; Su H
    BMC Cancer; 2021 May; 21(1):553. PubMed ID: 33993869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma.
    Jiao F; Sun H; Yang Q; Sun H; Wang Z; Liu M; Chen J
    Int J Med Sci; 2020; 17(11):1610-1624. PubMed ID: 32669964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering Immune-Associated Genes to Predict Survival in Clear Cell Renal Cell Cancer.
    Hu D; Zhou M; Zhu X
    Biomed Res Int; 2019; 2019():2506843. PubMed ID: 31886185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
    Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
    Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma.
    Xu C; Zeng H; Fan J; Huang W; Yu X; Li S; Wang F; Long X
    BMC Cancer; 2022 Mar; 22(1):264. PubMed ID: 35279104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.
    Chen J; Hou C; Wang P; Yang Y; Zhou D
    World Neurosurg; 2019 Dec; 132():e76-e88. PubMed ID: 31518750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of TNFSF14 on prognosis and immune microenvironment in clear cell renal cell carcinoma.
    Xu F; Guan Y; Zhang P; Xue L; Yang X; Gao K; Chong T
    Genes Genomics; 2020 Sep; 42(9):1055-1066. PubMed ID: 32725578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of microenvironment-related genes with prognostic value in clear cell renal cell carcinoma.
    Zhang Z; Li Z; Liu Z; Zhang X; Yu N; Xu Z
    J Cell Biochem; 2020 Jul; 121(7):3606-3615. PubMed ID: 31961022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
    Li C; Liu T; Liu Y; Zhang J; Zuo D
    J Cell Mol Med; 2021 Jun; 25(12):5811-5822. PubMed ID: 33949771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
    Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F
    Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative bioinformatics analysis of a prognostic index and immunotherapeutic targets in renal cell carcinoma.
    Tao H; Li Z; Mei Y; Li X; Lou H; Dong L; Zhou L
    Int Immunopharmacol; 2020 Oct; 87():106832. PubMed ID: 32738597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGLL5 is correlated with tumor-infiltrating immune cells in clear cell renal cell carcinoma.
    Xia ZN; Wang XY; Cai LC; Jian WG; Zhang C
    FEBS Open Bio; 2021 Mar; 11(3):898-910. PubMed ID: 33449444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis.
    Wu H; Fan L; Liu H; Guan B; Hu B; Liu F; Hocher B; Yin L
    Biomed Res Int; 2020; 2020():4030915. PubMed ID: 31998788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calbindin S100A16 Promotes Renal Cell Carcinoma Progression and Angiogenesis via the VEGF/VEGFR2 Signaling Pathway.
    Wang N; Wang R; Tang J; Gao J; Fang Z; Zhang M; Shen X; Lu L; Chen Y
    Contrast Media Mol Imaging; 2022; 2022():5602011. PubMed ID: 36176934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid metabolism-related gene expression in the immune microenvironment predicts prognostic outcomes in renal cell carcinoma.
    Zhang Q; Lin B; Chen H; Ye Y; Huang Y; Chen Z; Li J
    Front Immunol; 2023; 14():1324205. PubMed ID: 38090559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a novel glycolysis-related gene signature on progression, prognosis and immune microenvironment of renal cell carcinoma.
    Xu F; Guan Y; Xue L; Huang S; Gao K; Yang Z; Chong T
    BMC Cancer; 2020 Dec; 20(1):1207. PubMed ID: 33287763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.